Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Goodwill (2016 - 2017)

Soleno Therapeutics (SLNO) has disclosed Goodwill for 3 consecutive years, with $718000.0 as the latest value for Q1 2017.

  • On a quarterly basis, Goodwill changed 0.0% to $718000.0 in Q1 2017 year-over-year; TTM through Mar 2017 was $718000.0, a 0.0% change, with the full-year FY2016 number at $718000.0, down 21.68% from a year prior.
  • Goodwill was $718000.0 for Q1 2017 at Soleno Therapeutics, roughly flat from $718000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $916807.0 in Q4 2015 to a low of $718000.0 in Q3 2015.
  • A 3-year average of $746401.0 and a median of $718000.0 in 2015 define the central range for Goodwill.
  • Biggest YoY gain for Goodwill was 0.0% in 2016; the steepest drop was 21.68% in 2016.
  • Soleno Therapeutics' Goodwill stood at $916807.0 in 2015, then dropped by 21.68% to $718000.0 in 2016, then changed by 0.0% to $718000.0 in 2017.
  • Per Business Quant, the three most recent readings for SLNO's Goodwill are $718000.0 (Q1 2017), $718000.0 (Q4 2016), and $718000.0 (Q3 2016).